October 10, 2023 Key Pharma Commercialization Experts to Converge at Access Insights Conference 2023 The Access Insights Conference 2023 is sponsored by Asembia, AssistRx, BRG, ConnectiveRx, EntityRisk, Pharmaceutical Commerce, Phil, Redi.Health, and Turquoise Health.
September 12, 2023 IntegriChain Expert to Speak on the Inflation Reduction Act at MDRP Summit Pharmaceutical pricing and regulatory expert and Vice President of Operational Consulting Jeff Baab will speak on the impact of the Inflation Reduction Act (IRA) at the Medicaid Drug Rebate Reporting Summit 2023.
June 27, 2023 Blue Fin Group, an IntegriChain Company, Promotes Jason Bogroff to Partner Blue Fin Group promotes seasoned industry advisor Jason Bogroff to partner. In his new role, Bogroff will have direct client responsibility and will lead the firm’s Data Strategy area of focus.
June 22, 2023 IntegriChain and Verato Partner on Securing Patient Privacy Data IntegriChain and Verato announced a technology partnership in which IntegriChain utilize Verato’s healthcare master data management (hMDM) solution to create a new ICyte Secure PHI Vault for securing protected health information (PHI) and personal identifiable information (PII).
June 15, 2023 IntegriChain and Knipper Team Up to Support Emerging Pharmaceutical Manufacturers Preparing for Commercialization IntegriChain and Knipper Health announced a non-exclusive joint initiative to support emerging manufacturers launching new products that need comprehensive 3PL services, order-to-cash, government pricing, and claims adjudication support.
May 9, 2023 IntegriChain Expert to Speak on the Inflation Reduction Act at Informa’s Medicaid & Government Pricing Congress IntegriChain pharmaceutical pricing and regulatory expert and Vice President of Operational Consulting Jeff Baab will speak on the impact of the Inflation Reduction Act (IRA) at Informa’s Medicaid & Government Pricing Congress.
April 18, 2023 IntegriChain and Second Sight Solutions to Team up on 340B Issue Prevention for Pharma Manufacturers IntegriChain and Second Sight Solutions announced plans for a new joint initiative for 340B Drug Pricing Program duplicate discount prevention. The initiative, when implemented, will be capable of integrating 340B claims submitted by covered entities and contract pharmacies to Second Sight’s 340B ESP™ platform into IntegriChain’s ICyte® Script Management solution, which retrieves, validates, and reconciles all claims at scale.
April 11, 2023 Registration Opens for Access Insights Conference 2023 Registration is now open to all pharma manufacturers for the Access Insights Conference 2023, co-hosted by IntegriChain and Blue Fin Group. The Access Insights Conference will be held November 6-8, 2023, at the JW Marriott Orlando Bonnet Creek. Designed for commercial, operational, and financial teams at pharma manufacturers, the conference will feature industry panels, exclusive ICyte Benchmark data, and strategic and tactical best practices for data-driven patient access and therapy commercialization.
January 20, 2023 IntegriChain Appoints Josh Halpern Chief Executive Officer IntegriChain names Joshua Halpern, co-founder and current President and Chief Operating Officer, as new Chief Executive Officer effective February 1, 2023. Kevin Leininger, current CEO, will transition to the role of Executive Chairman and remain active in the business strategy.
